Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype

Adams, Paul; Altes, Albert; Brissot, Pierre; Butzeck, Barbara; Cabantchik, Ioav; Cançado, Rodolfo; Distante, Sonia; Evans, Patricia; Evans, Robert; Ganz, Tomas; Girelli, Domenico; Hultcrantz, Rolf; McLaren, Gordon; Marris, Ben; Milman, Nils; Nemeth, Elizabeta; Nielsen, Peter; Pineau, Brigitte; Piperno, Alberto; Porto, Graça; Prince, Dianne; Ryan, John; Sanchez, Mayka; Santos, Paulo; Swinkels, Dorine; Teixeira, Emerência; Toska, Ketil; Vanclooster, Annick; White, Desley; Contributors and Hemochromatosis International Taskforce

Abstract

Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.

Document Type

Article

Document version

Published version

Language

English

Subject (CDU)

61 - Medical sciences

Keywords

Medicina

Medicine

Publisher

Springer Nature

Collection

Is part of

Hepatology International

Citation

Adams, Paul; Altes, Albert; Brissot, Pierre [et al.]. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatology International, 2018, 12, p. 83-86. Disponible en: <https://link.springer.com/article/10.1007/s12072-018-9855-0>. Fecha de acceso: 31 ene. 2024. DOI: 10.1007/s12072-018-9855-0

Show full item record

This item appears in the following Collection(s)

Ciències de la Salut [965]